Chia Tai Enterprises International Ltd

03839

Company Profile

  • Business description

    Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of chlortetracycline (CTC) and animal health products. The company's operating segments include Biochemical operations and Industrial operations. It generates maximum revenue from the Biochemical operations segment, which is engaged in the manufacture and sale of chlortetracycline and animal health products. The Industrial segment is into the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.

  • Contact

    16 Harcourt Road
    21st Floor, Far East Finance Centre
    Hong Kong
    HKG

    T: +852 25201601

    http://www.ctei.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    900

Stocks News & Analysis

stocks

Picking dividend shares in 2026? Here’s where to look

A new report from Morningstar shows opportunities for income investors.
stocks

Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?

With outstanding long-term estimates, here’s what we think of Nvidia stock.
stocks

Wide moat ASX listed global leader keeps winning

Latest earnings show continued strength.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,721.4031.90-0.36%
CAC 408,003.5635.630.45%
DAX 4023,370.76190.230.82%
Dow JONES (US)46,279.23187.490.41%
FTSE 1009,559.787.480.08%
HKSE25,830.6599.38-0.38%
NASDAQ22,807.28374.431.67%
Nikkei 22548,537.70165.28-0.34%
NZX 50 Index13,326.9015.92-0.12%
S&P 5006,687.1469.821.06%
S&P/ASX 2008,447.9035.60-0.42%
SSE Composite Index3,946.746.930.18%

Market Movers